BOCA RATON, FL--(Marketwire - Dec 4, 2012) - Noble Financial Capital Markets (Noble) announced today that it has established a scientific advisory board (SAB). Jules Musing, a Large Pharma veteran who will chair the Board, is excited about the developmental prospects for the SAB. "Establishment of this Board represents a bold strategic initiative for Noble," said Musing. "Not only are innovations in the Healthcare sector moving forward at a blistering speed, the regulatory and scientific process has become exceedingly complex and it takes this kind of commitment to establish credibility with the various constituents," he said.